Kevin McGovern, McGovern Capital

McGovern Capital

Kevin McGovern is the Chairman and CEO of McGovern Capital.  Through McGovern Capital and its affiliates, he has co-founded over twenty-five (25) companies, six of which have become world/category leaders, and he has been lead negotiator/principal in over fifteen (15) global joint ventures.  McGovern Capital serves as an investment, strategy and licensing participant and advisor to global businesses.  He owns McGovern & Associates which provided legal counsel to certain of the largest acquisition funds in the world.

McGovern was a founder of SoBe Beverages, the fastest growing beverage company ever in the US (sold to Pepsi), and McGovern Capital was one of three owners of KX Industries, L.P., the largest manufacturer and worldwide source of carbon water purification filters, having invented and supplied PUR to P&G, the first end-of-tap filter to Brita, and the first refrigerator water filter to Electrolux. He also created the program, supervised and negotiated all licensing of Tristrata’s alpha hydroxy acid (AHA) patents, which technology was incorporated in approximately 40% of all global skin care products, and is/was sold in approximately 84 countries.  Mr. McGovern has spent well over the last decade working to provide clean drinking water to people with the worst water contamination issues (including bacteria, viruses, arsenic and lead).  He serves/served on many public and private boards including The Sports Authority (Exec. Committee – NYSE).

McGovern Capital is also currently involved in several consumer technologies including innovative foods and beverages; several teams/organizations in e-Sports; and building wellness facilities for Native Indians.

McGovern is actively involved in the medical cannabis industry with numerous companies across the globe.  He is Co-Chairman of Israel Plant Sciences which has numerous subsidiaries working on uniform seed breeding for all agricultural purposes and cutting edge drug solutions for intestinal bowel disease (IBD), addictions, and colon cancer.  Kanativa and Intiva BioPharma develop cannabis related drug and medical solutions and Intiva BioPharma (Stock: NTVA) is a leader of orphan cannabis drug development.  He is a member of the Board of WeedMD, a licensed Canadian medical marijuana producer and dispense McGovern is actively involved in the medical cannabis industry with numerous companies across the globe.  He is Co-Chairman of Israel Plant Sciences which has numerous subsidiaries working on uniform seed breeding for all agricultural purposes and cutting edge drug solutions for intestinal bowel disease (IBD), addictions, and colon cancer.  Kanativa and Intiva BioPharma develop cannabis related drug and medical solutions and Intiva BioPharma (Stock: NTVA) is a leader of orphan cannabis drug development.  He is a member of the Board of WeedMD, a licensed Canadian medical marijuana producer and dispenser, which has one of its specialties to provide cannabis related healthcare to the elderly.